Last updated 2026-06-18
- Raised $12M funding round, Mar 2023
- Raised $8M funding round led by Grove Ventures, Jan 2022
Total raised
$20.0M
Last: 2023-03
Stage
Seed
Founded
2021
Headcount
25
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered. The company is building machine learning models combining deep proteomics to identify up to 1 million proteoforms, including post-translational modifications, protein-protein interactions, quantifications, and different structural populations of proteins.
Funding history · 2 rounds · $20.0M total
2023-03
2022-01
Q&A
- What is Protai's primary focus?
- Protai operates an end-to-end AI-based platform that maps the course of disease at the protein level to enhance cellular function observation and improve drug discovery.
- When was Protai founded?
- Protai was founded in July 2021.
- How much funding has Protai raised to date?
- Protai has raised a total of $20,000,000 USD.
- When did Protai complete its most recent funding round and who were the investors?
- Protai completed its most recent funding round in March 2023, with participation from Pitango HealthTech and Grove Ventures.
- Who are the co-founders of Protai?
- The co-founders of Protai are Eran Seger, who serves as CEO, and Kirill Pevzner, who serves as CTO.
- What technologies does Protai utilize in its platform?
- Protai utilizes Artificial Intelligence, Machine Learning, Platforms & Interfaces, and Software in its technology stack.
- In which sector does Protai primarily operate?
- Protai's primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
Team · 2
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMachine LearningPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
data-analyticsbiotechnologydecision-supportdisease-managementproteinsdigital-healthcareartificial-intelligencedrug-discoverypersonalizationsoftware-platformpharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | protai.bio |
|---|---|
| linkedin.com/company/74514047 |
Identifiers & details
| Founded | 2021-7 |
|---|---|
| Employees (exact) | 25 |
Radar intelligence
Patents
| EPO | 51 |
|---|
Publications (Crossref)
| Works | 3 |
|---|
GitHub
| Top repos | co-folding-benchmark |
|---|
Web history (Wayback)
| Domain | protai.bio |
|---|